# Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL®

> **NCT00355121** · PHASE2 · COMPLETED · sponsor: **Sanofi** · enrollment: 882 (actual)

## Conditions studied

- Meningococcal Meningitis
- Tetanus
- Diphtheria
- Pertussis
- Poliomyelitis

## Interventions

- **BIOLOGICAL:** Polysaccharide Diphtheria Toxoid Conjugate Vaccine
- **BIOLOGICAL:** Polysaccharide Diphtheria Toxoid Conjugate Vaccine
- **BIOLOGICAL:** Polysaccharide Diphtheria Toxoid Conjugate Vaccine

## Key facts

- **NCT ID:** NCT00355121
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2009-06
- **Final completion:** 2009-07
- **Target enrollment:** 882 (ACTUAL)
- **Last updated:** 2011-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00355121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00355121, "Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL®". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00355121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*